ReviewTargeted oncology2024

Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review.

Nathan Hale Fowler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.